Average Insider

Where insiders trade, we follow

Collins Helen Louise

CHIEF MEDICAL OFFICER
CIK: 1701247

All Transactions

DateCompanyTypeSharesPriceValueActions
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S63$53.92$3,397.01View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S2,184$53.42$116,669.06View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S231$50.05$11,562.52View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S2,063$52.39$108,084.90View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$2.48$12,400.00View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)S459$51.55$23,659.89View Details Filing
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$0.00$0.00View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)S1,133$44.74$50,693.82View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$2.48$12,400.00View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)S1,268$42.83$54,304.64View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)S2,599$43.87$114,018.39View Details Filing
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$0.00$0.00View Details Filing
Jun 4, 2026Kura Oncology, Inc. (KURA)A35,000$0.00$0.00View Details Filing
May 18, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$2.48$12,400.00View Details Filing
May 18, 2026Enliven Therapeutics, Inc. (ELVN)M5,000$0.00$0.00View Details Filing
May 18, 2026Enliven Therapeutics, Inc. (ELVN)S223$41.21$9,188.76View Details Filing
May 18, 2026Enliven Therapeutics, Inc. (ELVN)S1,302$40.25$52,401.98View Details Filing
May 18, 2026Enliven Therapeutics, Inc. (ELVN)S3,475$39.53$137,380.65View Details Filing
22 more transactions available โ€” create a free account to see 12 months of history
Version: v26.7.3